Cargando…
Global economic burden per episode for multiple diseases caused by group A Streptococcus
Considering the lack of existing evidence on economic burden for diseases caused by group A Streptococcus, we estimated the economic burden per episode for selected diseases. Each cost component of direct medical costs (DMCs), direct non-medical costs (DNMCs), and indirect costs (ICs) was separately...
Autores principales: | Lee, Jung-Seok, Kim, Sol, Excler, Jean-Louis, Kim, Jerome H., Mogasale, Vittal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184078/ https://www.ncbi.nlm.nih.gov/pubmed/37188693 http://dx.doi.org/10.1038/s41541-023-00659-1 |
Ejemplares similares
-
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts
por: Lee, Jung-Seok, et al.
Publicado: (2023) -
Model-based estimation of the economic burden of cholera in Africa
por: Mogasale, Vittal, et al.
Publicado: (2021) -
Accelerating the development of a group A Streptococcus vaccine: an urgent public health need
por: Excler, Jean-Louis, et al.
Publicado: (2016) -
Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings
por: Hsiao, Amber, et al.
Publicado: (2017) -
Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990–2018
por: Kim, Samuel, et al.
Publicado: (2019)